Florida has become the second U.S. state to ban fluoride in its public water systems, following a controversial trend among Republican-led states. Governor Ron DeSantis signed the legislation on Thursday, calling the addition of fluoride to tap water “forced medication.” The ban takes effect on July 1.
Fluoride, a naturally occurring mineral found in water, soil, and air, has been widely used for decades to prevent cavities and strengthen teeth. About 63% of Americans currently receive fluoridated water, according to the CDC. Public health organizations, including the American Dental Association (ADA), argue that fluoridation significantly improves dental health and poses no proven harm. However, fluoride has faced growing political opposition, especially from figures like DeSantis and Health Secretary Robert F. Kennedy Jr., who link it to health risks such as cancer and reduced cognitive function in children—claims the American Cancer Society says lack strong evidence.
DeSantis, who previously opposed public health mandates during the COVID-19 pandemic, said medical experts “shouldn’t be able to decree how we live our lives,” criticizing what he sees as overreach by health authorities.
Utah became the first state to enact a similar ban in March. Meanwhile, the FDA is currently reviewing the safety of fluoride supplements for children, signaling broader scrutiny of the mineral’s use in public health.
The ADA strongly opposes these moves, urging a thorough review before policy changes are made. President Brett Kessler emphasized the need to “slow down” and fully assess the implications of banning fluoride for national health.
The fluoride debate is intensifying as Republican states challenge long-standing public health practices, raising questions about science, personal choice, and government intervention in health policy.


Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
U.S.-Russia Talks in Miami Raise Hopes for Potential Ukraine War Deal
Trump Attends Dover Ceremony Honoring U.S. Personnel Killed in Syria
Trump Weighs Reclassifying Marijuana as Schedule III, Potentially Transforming U.S. Cannabis Industry
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
U.S. Senators Move Toward Deal to Strengthen Military Helicopter Safety Rules
Trump Administration Plans Major Increase in Denaturalization Cases for Naturalized U.S. Citizens
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Trump Expands U.S. Travel Ban to Antigua and Barbuda, Dominica, Sparking Economic Fears in the Caribbean
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Australia Pushes Forward on AUKUS Submarine Program Amid Workforce and Production Challenges
Trump Signs Order to Ease Federal Marijuana Rules, Signaling Major Policy Shift
U.S. Initiates $11.1 Billion Arms Sale to Taiwan Amid Rising China Tensions
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 



